Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03531242 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Immunogenicity Study of Venezuelan Equine Encephalomyelitis (VEE) Vaccine as Booster Vaccine in Adults

Study acronym: VEE
StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 16, 2021 (before its estimated December 2023 completion). Its status may not reflect the trial's current state.

Record History

  1. Start date: Dec 2019 to Jun 2021v5
  2. Start date: Jun 2019 to Dec 2019v4
  3. Start date: Dec 2018 to Jun 2019v3
  4. Start date: Jun 2018 to Dec 2018v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to evaluate the safety and immunogenicity of VEE vaccine, C-84, TSI-GSD 205, Lot 7, Run 1, and collect data on the incidence of occupational VEE infection in vaccinated personnel.
Trial Details
NCT Number NCT03531242
Lead Sponsor U.S. Army Medical Research and Development Command
Conditions
(from sponsor)		 Venezuelan Equine Encephalomyelitis
Related terms Encephalomyelitis, Venezuelan Equine
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov